Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Practical implementation, education and interpretation guidelines for continuous glucose monitoring: A French position statement.
Borot S, Benhamou PY, Atlan C, Bismuth E, Bonnemaison E, Catargi B, Charpentier G, Farret A, Filhol N, Franc S, Gouet D, Guerci B, Guilhem I, Guillot C, Jeandidier N, Joubert M, Melki V, Merlen E, Penfornis A, Picard S, Renard E, Reznik Y, Riveline JP, Rudoni S, Schaepelynck P, Sola-Gazagnes A, Tubiana-Rufi N, Verier-Mine O, Hanaire H; Société francophone du diabète (SFD), Société française d’endocrinologie (SFE); Évaluation dans le diabète des implants actifs Group (EVADIAC). Borot S, et al. Among authors: merlen e. Diabetes Metab. 2018 Feb;44(1):61-72. doi: 10.1016/j.diabet.2017.10.009. Epub 2017 Nov 11. Diabetes Metab. 2018. PMID: 29174479
Indication, organization, practical implementation and interpretation guidelines for retrospective CGM recording: A French position statement.
Joubert M, Baillot-Rudoni S, Catargi B, Charpentier G, Esvant A, Franc S, Guerci B, Guilhem I, Melki V, Merlen E, Penfornis A, Renard E, Riveline JP, Schaepelynck P, Sola-Gazagnes A, Hanaire H; Société Francophone du Diabète (SFD); Société Française d’Endocrinologie (SFE); EVAluation dans le Diabète des Implants ACtifs Group (EVADIAC). Joubert M, et al. Among authors: merlen e. Diabetes Metab. 2015 Dec;41(6):498-508. doi: 10.1016/j.diabet.2015.07.001. Epub 2015 Aug 7. Diabetes Metab. 2015. PMID: 26260529
French Endocrine Society Guidance on endocrine side effects of immunotherapy.
Castinetti F, Albarel F, Archambeaud F, Bertherat J, Bouillet B, Buffier P, Briet C, Cariou B, Caron P, Chabre O, Chanson P, Cortet C, Do Cao C, Drui D, Haissaguerre M, Hescot S, Illouz F, Kuhn E, Lahlou N, Merlen E, Raverot V, Smati S, Verges B, Borson-Chazot F. Castinetti F, et al. Among authors: merlen e. Endocr Relat Cancer. 2019 Feb;26(2):G1-G18. doi: 10.1530/ERC-18-0320. Endocr Relat Cancer. 2019. PMID: 30400055 Free PMC article.
Beyond MEN1, when to think about MEN4? Retrospective study on 5600 patients in the French population & literature review.
Chevalier B, Coppin L, Romanet P, Cuny T, Maiza JC, Abeillon J, Forestier J, Walter T, Gilly O, Le Bras M, Smati S, Nunes ML, Geslot A, Grunenwald S, Mouly C, Arnault G, Wagner K, Koumakis E, Cortet-Rudelli C, Merlen É, Jannin A, Espiard S, Morange I, Baudin É, Cavaille M, Tauveron I, Teissier MP, Borson-Chazot F, Mirebeau-Prunier D, Savagner F, Pasmant É, Giraud S, Vantyghem MC, Goudet P, Barlier A, Cardot-Bauters C, Odou MF. Chevalier B, et al. Among authors: merlen e. J Clin Endocrinol Metab. 2024 Jan 30:dgae055. doi: 10.1210/clinem/dgae055. Online ahead of print. J Clin Endocrinol Metab. 2024. PMID: 38288531
How to diagnose a lipodystrophy syndrome.
Vantyghem MC, Balavoine AS, Douillard C, Defrance F, Dieudonne L, Mouton F, Lemaire C, Bertrand-Escouflaire N, Bourdelle-Hego MF, Devemy F, Evrard A, Gheerbrand D, Girardot C, Gumuche S, Hober C, Topolinski H, Lamblin B, Mycinski B, Ryndak A, Karrouz W, Duvivier E, Merlen E, Cortet C, Weill J, Lacroix D, Wémeau JL. Vantyghem MC, et al. Among authors: merlen e. Ann Endocrinol (Paris). 2012 Jun;73(3):170-89. doi: 10.1016/j.ando.2012.04.010. Epub 2012 Jun 28. Ann Endocrinol (Paris). 2012. PMID: 22748602 Review.
Expert opinion on pituitary complications in immunotherapy.
Briet C, Albarel F, Kuhn E, Merlen E, Chanson P, Cortet C. Briet C, et al. Among authors: merlen e. Ann Endocrinol (Paris). 2018 Oct;79(5):562-568. doi: 10.1016/j.ando.2018.07.008. Epub 2018 Jul 25. Ann Endocrinol (Paris). 2018. PMID: 30126625 Review.
Endocrine side-effects of new anticancer therapies: Overall monitoring and conclusions.
Castinetti F, Albarel F, Archambeaud F, Bertherat J, Bouillet B, Buffier P, Briet C, Cariou B, Caron P, Chabre O, Chanson P, Cortet C, Do Cao C, Drui D, Haissaguerre M, Hescot S, Illouz F, Kuhn E, Lahlou N, Merlen E, Raverot V, Smati S, Verges B, Borson-Chazot F. Castinetti F, et al. Among authors: merlen e. Ann Endocrinol (Paris). 2018 Oct;79(5):591-595. doi: 10.1016/j.ando.2018.07.005. Epub 2018 Jul 11. Ann Endocrinol (Paris). 2018. PMID: 30056975 Review.
Efficacy of lanreotide 120 mg primary therapy on tumour shrinkage and ophthalmologic symptoms in acromegaly after 1 month.
Benderradji H, Vernotte E, Soto Ares G, Woillez JP, Jannin A, Perbet R, Karnoub MA, Soudan B, Assaker R, Buée L, Prevot V, Maurage CA, Pigny P, Vantyghem MC, Merlen E, Cortet C. Benderradji H, et al. Among authors: merlen e. Clin Endocrinol (Oxf). 2022 Jul;97(1):52-63. doi: 10.1111/cen.14748. Epub 2022 May 5. Clin Endocrinol (Oxf). 2022. PMID: 35470446
17 results